Blogue

BLOGUE2021-09-20T12:18:42+00:00

Consultez notre blogue pour resté informé à propos de nos événements à venir ainsi qu’aux plus récents développements dans le domaine de la génomique. Veuillez noter que les blogues sont publiés ici dans leur langue d’origine seulement.

Website re-design

New C3G Website By David Anderson Re-designing a website can be a complex task, especially an existing website. There are many factors to consider during the process. Such as the content, structure, navigation, functionality, images, and the goal and mission. In the article, I will explain the process behind [Read more]

A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Quebec, Canada

A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Quebec, Canada In April 2020, the Coronavirus Sequencing in Québec (CoVSeQ) consortium was assembled to sequence SARS-CoV-2 genomes in Québec to track viral introduction events and transmission within the province. Jose Hector Galvez, Pierre-Olivier Quirion, Paul Stretenowich, [Read more]

Platforms to help identify asymptomatic carriers of COVID-19

Platforms to help identify asymptomatic carriers of COVID-19 Identifying asymptomatic carriers of the novel coronavirus is crucial in preventing the spread of COVID-19, particularly in healthcare settings. C3G’s Toronto Node has developed several applications for this purpose across various health institutions. The Mt. Sinai Hospital and Lunenfeld-Tanenbaum Research Institute’s [Read more]

Understanding why persons living with HIV are at increased risk of tuberculosis

Understanding why persons living with HIV are at increased risk of tuberculosis Persons living with HIV (PLWH) are at increased risk of tuberculosis (TB). HIV-associated TB is often the result of a recent infection with Mycobacterium tuberculosis (Mtb) followed by rapid progression to the disease. Alveolar macrophages (AM) are [Read more]

STOP-CoV: Examining COVID-19 vaccination responses across age groups

STOP-CoV: Examining COVID-19 vaccination responses across age groups As the rollout for COVID-19 vaccinations continues across Ontario the C3G Toronto Node has helped establishSTOP-CoV (SafeTy and Efficacy of Preventative COVID Vaccines), a province-wide study to examine the differences in COVID-19 vaccine responses between younger and older individuals. Participants contribute [Read more]

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 Host genetic factors related to COVID-19 susceptibility and outcomes are of great interest, as their identification could elucidate the mechanisms of SARS-CoV-2 infection and severity, thereby providing clues about potential therapeutic targets. A recent [Read more]

Go to Top